HEIGHTS CAPITAL MANAGEMENT
Heights Capital Management, Inc. is a private equity firm specializing in private investments in public equity in emerging growth companies. The firm typically invests in healthcare and technology companies. Heights Capital Management, Inc. was founded in 1996 and is based in San Francisco, California.
HEIGHTS CAPITAL MANAGEMENT
Founded:
1996-01-01
Status:
Active
Similar Organizations
Bascom Ventures
Bascom Ventures is a Venture Capital and Private Equity firm that specializes in investing across various sectors.
Lightrock
Lightrock is a global private equity platform that backs purpose-driven entrepreneurs tackling the world’s biggest challenges.
LLR Partners
LLR Partners, a private equity firm based in Philadelphia, Pennsylvania, provides capital to middle market growth companies.
Oaktree Capital Management
Oaktree Capital Management is a privately owned investment manager specializing in alternative investment strategies.
Tiger Global Management
Tiger Global Management is an investment firm that deploys capital globally in both public and private markets.
Versa Capital Management
Versa Capital Management, Inc. is private equity investment firm with $950 million of committed capital focused on control investments in
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-15 | Ribbon Communications | Heights Capital Management investment in Post-IPO Equity - Ribbon Communications | 52 M USD |
| 2022-03-16 | 2seventy bio | Heights Capital Management investment in Post-IPO Equity - 2seventy bio | 170 M USD |
| 2022-03-01 | Modulus Discovery | Heights Capital Management investment in Series C - Modulus Discovery | 2.34 B JPY |
| 2021-02-25 | Cullgen | Heights Capital Management investment in Series B - Cullgen | 50 M USD |
| 2020-11-25 | MedAvail | Heights Capital Management investment in Series E - MedAvail | 96.99 M USD |
| 2010-09-24 | Cascadian Therapeutics | Heights Capital Management investment in Post-IPO Equity - Cascadian Therapeutics | 14.9 M USD |
| 2010-08-09 | Raptor Pharmaceuticals | Heights Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals | 15 M USD |
| 2010-03-29 | Sevion Therapeutics | Heights Capital Management investment in Post-IPO Equity - Sevion Therapeutics | 11.5 M USD |
| 2010-02-24 | SinoHub | Heights Capital Management investment in Venture Round - SinoHub | 4.61 M USD |
| 2007-06-28 | EUSA Pharma | Heights Capital Management investment in Venture Round - EUSA Pharma | 9.1 M USD |